Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 8/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | TP53 | P04637 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | MITF | O75030 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | XBP1 | P17861 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nifurtimox SCHEMBL1650162 | 1.00 | LMNA (1.00) | LMNAALDH1A1MAPTSMN1; SMN2TP53 | |
| Nifurtimox SCHEMBL9910611 | 1.00 | LMNA (1.00) | LMNAALDH1A1MAPTSMN1; SMN2TP53 | |
| Nifurtimox SCHEMBL60840 | 1.00 | LMNA (1.00) | LMNAALDH1A1MAPTSMN1; SMN2TP53 | |
| Nifurtimox SCHEMBL4727154 | 0.92 | LMNA (0.85) | LMNAALDH1A1MAPTSMN1; SMN2TP53 | |
| Nifurtimox SCHEMBL2326415 | 0.91 | LMNA (0.83) | LMNAALDH1A1MAPTSMN1; SMN2TP53 | |
| SCHEMBL23003602 | 0.88 | LMNA (0.78) | LMNAALDH1A1MAPTSMN1; SMN2TP53 | |
| SCHEMBL23003603 | 0.88 | LMNA (0.78) | LMNAALDH1A1MAPTSMN1; SMN2TP53 | |
| Nifurtimox SCHEMBL2326559 | 0.84 | LMNA (0.70) | LMNAALDH1A1MAPTSMN1; SMN2TP53 | |
| SCHEMBL12609083 | 0.80 | LMNA (0.67) | LMNAALDH1A1MAPTSMN1; SMN2TP53 | |
| SCHEMBL368127 | 0.78 | LMNA (0.64) | LMNAALDH1A1MAPTSMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4859 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260091119-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | CELLIS AG (CH) | 2026-04-02 | — | — | US | claimed |
| EP-4659760-A1 | THERAPEUTIC IMMUNE INTERVENTION | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2025-12-10 | — | — | EP | claimed |
| EP-4637829-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF OVARIAN CANCER | Cellis Sp. z o.o. ([Ltd.] (PL) | 2025-10-29 | — | — | EP | claimed |
| EP-4587062-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | Cellis AG (CH) | 2025-07-23 | — | — | EP | claimed |
| US-20250222066-A1 | COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2025-07-10 | — | — | US | claimed |
| US-12295957-B2 | Ascorbic acid and quinone compounds in combination with an antiparasitic agent for treating a parasitic disease | IC-MedTech Corp. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4547023-A2 | COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION | University of Utah Research Foundation (US) | 2025-05-07 | — | — | EP | claimed |
| WO-2025076059-A1 | ROCAGLATE DERIVATIVES AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-04-10 | — | — | WO | claimed |
| US-20250084059-A1 | CRYSTALLINE FORMS OF C21H22Cl2N4O2 | BIOMED VALLEY DISCOVERIES INC (US) | 2025-03-13 | — | — | US | claimed |
| JP-2001500477-A | — | — | 2001-01-16 | — | — | JP | claimed |
| EP-0925308-A2 | COMPOSITIONS AND METHODS FOR TREATING INFECTIONS USING ANALOGUES OF INDOLICIDIN | Micrologix Biotech, Inc. (CA) | 1999-06-30 | — | — | EP | claimed |
| WO-1998007745-A2 | COMPOSITIONS AND METHODS FOR TREATING INFECTIONS USING ANALOGUES OF INDOLICIDIN | MICROLOGIX BIOTECH, INC. (CA) | 1998-02-26 | — | — | WO | claimed |
| US-5646114-A | Anti-protozoan methods | XOMA CORPORATION (US) | 1997-07-08 | — | — | US | claimed |
| EP-0364559-B1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | SCRIPPS RESEARCH INST (US) | 1995-09-20 | — | — | EP | claimed |
| US-5332747-A | Method for potentiating primary drugs in treating multidrug resistant parasitic disease cells | CANCER BIOLOGICS OF AMERICA, INC. (US) | 1994-07-26 | — | — | US | claimed |
| EP-0364559-A4 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | — | 1991-01-09 | — | — | EP | claimed |
| EP-0364559-A1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS. | SCRIPPS CLINIC RES (US) | 1990-04-25 | — | — | EP | claimed |
| WO-1989008658-A1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-09-21 | — | — | WO | claimed |
| EP-0305968-A2 | Compositions against protozoal diseases | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1989-03-08 | — | — | EP | claimed |